• https://world-signals.com/news/2022/12/10/rod-stewart-declared-all-unvaccinated-people-murderers-a-year-later-mass-death-in-his-family/
    Rod Stewart declared all unvaccinated people "killers". A year later mass death in his family
    #news #unitedkingdom #vaccine #sideeffects #unvaccinated #covid #covid19 #suddendeath
    https://world-signals.com/news/2022/12/10/rod-stewart-declared-all-unvaccinated-people-murderers-a-year-later-mass-death-in-his-family/ Rod Stewart declared all unvaccinated people "killers". A year later mass death in his family #news #unitedkingdom #vaccine #sideeffects #unvaccinated #covid #covid19 #suddendeath
    0 Comments 0 Shares
  • https://arthritistreatment.one/heal-soothe-pain-relief-anti-inflammatory Stop taking dangerous pharma (particularly covid-19 related vaccines as they are causing autoimmune issues like rheumatoid arthritis.) They never heal or cure your arthritis only cause more joint destruction and a compromised immune system. Natural Arthritis Remedies stop your arthritis and joint pain without harmful side effects. It can also help you reverse your arthritis by healing the joint tissue damage and creating a smooth arthritis free joint. Restores range of motion without pain. Not just a Band-Aid but true healing from mother nature! #arthritis #rheumatoid #covid -19 #inflammation #health
    https://arthritistreatment.one/heal-soothe-pain-relief-anti-inflammatory Stop taking dangerous pharma (particularly covid-19 related vaccines as they are causing autoimmune issues like rheumatoid arthritis.) They never heal or cure your arthritis only cause more joint destruction and a compromised immune system. Natural Arthritis Remedies stop your arthritis and joint pain without harmful side effects. It can also help you reverse your arthritis by healing the joint tissue damage and creating a smooth arthritis free joint. Restores range of motion without pain. Not just a Band-Aid but true healing from mother nature! #arthritis #rheumatoid #covid -19 #inflammation #health
    1
    0 Comments 0 Shares
  • https://world-signals.com/news/2022/12/08/a-university-requires-two-additional-vaccines-from-its-students/
    A university requires two additional vaccines from its students
    #news #usa #america #students #politics #mandates #university #vaccine #booster
    https://world-signals.com/news/2022/12/08/a-university-requires-two-additional-vaccines-from-its-students/ A university requires two additional vaccines from its students #news #usa #america #students #politics #mandates #university #vaccine #booster
    0 Comments 0 Shares
  • The at-home self-testing kits market is projected to grow at a healthy pace, till 2035, claims Roots Analysis

    Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes.

    London
    Roots Analysis has announced the addition of the “At home testing Kits Market , 2022–2035” report to its list of offerings.
    Owing to several advantages offered by at-home self-testing kits for diagnostics and screening purposes, industry stakeholders have undertaken numerous R&D initiatives focused on exploiting the use of such kits to provide healthcare at a fraction of a cost to the general public when compared to traditional clinics. Associated cost saving and privacy are main drivers of the growth of this domain over the coming decade. The ongoing innovations in this market are anticipated to bring a positive revolution in the healthcare domain. Given the continuous efforts being undertaken by industry players, the at-home self testing kits market is poised to witness healthy growth over the next decade.

    To request a sample copy / brochure of this report, please visit this
    https://www.rootsanalysis.com/reports/self-testing-kits-market/request-sample.html

    Key Market Insights
    Presently, more than 51% of the total at-home self-testing kit developers are based in North America
    This segment of the industry is dominated by the presence of companies that were established pre-2000 (37%), followed by firms established during 2000-2010 (32%). In addition, most of the players engaged in this domain are very small and small firms (less than 100 employees), representing close to 60% of the total kit developers.

    Over 500 at-home self testing kits are currently available in the market
    It is worth noting that most of the at home testing kits are currently being used for monitoring disorders (43%), followed by those employed for detection of conditions related to fertility and reproductive health (22%). Further, most of the kits are being developed to follow invasive route for the procurement of analyte (56%), followed by those being manufactured to utilize non-invasive methods for procuring analyte (43%).

    More than 1,130 grants have been awarded to support the ongoing research efforts in this domain
    Several non-profit organizations have extended financial support to aid the research related to at-home self-testing kits. It is worth mentioning that NIAID emerged as the most prominent non-profit organization, having awarded over 23% of grants for a period of 1-5 years, followed by NHLBI (12%).

    The demand for at-home self-testing kits is projected to grow at a rapid pace, in the foreseen future
    It is worth highlighting that the demand for HIV screening kits is expected to grow at a rate of 13%. Further, the highest demand for such products is expected to be driven by the Asia-Pacific region in 2035 (56%).

    The market is poised to be well distributed across different types of biofluids analyzed, till 2035
    The current market is driven by kits developed for metabolic disorders (64%); this trend is unlikely to change in the foreseen future as well. Further, based on type of test format, strip-based tests are likely to have the maximum revenue generation potential (50%), by 2035.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/self-testing-kits-market.html

    You may also be interested in the following titles:
    1. Viral Vaccine Cell Culture Media Market: Industry Trends and Global Forecasts, 2022-2035
    2. Next Generation Sequencing (NGS) Kits Market: Industry Trends and Global Forecasts, 2022-2035

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    +44 (122) 391 1091
    Ben.johnson@rootsanalysis.com


    The at-home self-testing kits market is projected to grow at a healthy pace, till 2035, claims Roots Analysis Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes. London Roots Analysis has announced the addition of the “At home testing Kits Market , 2022–2035” report to its list of offerings. Owing to several advantages offered by at-home self-testing kits for diagnostics and screening purposes, industry stakeholders have undertaken numerous R&D initiatives focused on exploiting the use of such kits to provide healthcare at a fraction of a cost to the general public when compared to traditional clinics. Associated cost saving and privacy are main drivers of the growth of this domain over the coming decade. The ongoing innovations in this market are anticipated to bring a positive revolution in the healthcare domain. Given the continuous efforts being undertaken by industry players, the at-home self testing kits market is poised to witness healthy growth over the next decade. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/self-testing-kits-market/request-sample.html Key Market Insights Presently, more than 51% of the total at-home self-testing kit developers are based in North America This segment of the industry is dominated by the presence of companies that were established pre-2000 (37%), followed by firms established during 2000-2010 (32%). In addition, most of the players engaged in this domain are very small and small firms (less than 100 employees), representing close to 60% of the total kit developers. Over 500 at-home self testing kits are currently available in the market It is worth noting that most of the at home testing kits are currently being used for monitoring disorders (43%), followed by those employed for detection of conditions related to fertility and reproductive health (22%). Further, most of the kits are being developed to follow invasive route for the procurement of analyte (56%), followed by those being manufactured to utilize non-invasive methods for procuring analyte (43%). More than 1,130 grants have been awarded to support the ongoing research efforts in this domain Several non-profit organizations have extended financial support to aid the research related to at-home self-testing kits. It is worth mentioning that NIAID emerged as the most prominent non-profit organization, having awarded over 23% of grants for a period of 1-5 years, followed by NHLBI (12%). The demand for at-home self-testing kits is projected to grow at a rapid pace, in the foreseen future It is worth highlighting that the demand for HIV screening kits is expected to grow at a rate of 13%. Further, the highest demand for such products is expected to be driven by the Asia-Pacific region in 2035 (56%). The market is poised to be well distributed across different types of biofluids analyzed, till 2035 The current market is driven by kits developed for metabolic disorders (64%); this trend is unlikely to change in the foreseen future as well. Further, based on type of test format, strip-based tests are likely to have the maximum revenue generation potential (50%), by 2035. For additional details, please visit https://www.rootsanalysis.com/reports/self-testing-kits-market.html You may also be interested in the following titles: 1. Viral Vaccine Cell Culture Media Market: Industry Trends and Global Forecasts, 2022-2035 2. Next Generation Sequencing (NGS) Kits Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com
    Request Sample - At-home Self Testing Kits Market | Market Size | Industry Analysis | 2035
    Owing to rising demand for infectious disease kits and 500+ marketed / under development self-testing kits, at-home self testing kits market is anticipated to witness a rapid growth in the coming years
    0 Comments 0 Shares
  • THE PHARMACEUTICAL INDUSTRY IS PRESENTLY EXPERIENCING A PROMINENT NEED FOR BIOAVAILABILITY ENHANCEMENT TECHNOLOGIES AND SERVICES

    Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug.

    Bioavailability refers to the proportion of a drug that reaches systemic circulation unaltered, post dose administration. Additionally, it is a direct consequence of the absorption potential of an active pharmaceutical ingredient (API). The bioavailability of a drug is dependent on several factors, such as solubility, route of administration and metabolism of the drug post administration. The following figure provides different factors that have been reported to impact drug bioavailability either directly or indirectly.

    To request a sample copy / brochure of this report, please visit
    https://www.rootsanalysis.com/reports/198/request-sample.html

     Solubility: The solubility of a substance refers to its ability to dissolve in a solvent and form a homogeneous system. Drug solubility is considered to be one of the most important factors responsible for enabling a therapeutic intervention to be efficiently distributed via systemic circulation. It is worth highlighting that a drug’s solubility is directly proportional to its bioavailability and hence, is one of the primary parameters that is modified during bioavailability enhancement
     Permeability: Permeability refers to the ability of a molecule to pass through biological membranes. Similar to solubility, drug permeability plays a key role in its absorption and systemic distribution. Membrane based efflux mechanisms and other structural barriers are the major biological elements responsible for poor permeability of drugs. Permeability of a drug is also proportional to its bioavailability; however, it is possible to improve this characteristic by modifying the physiochemical properties of the drug to render them more suitable for absorption across different types of biological membranes.
     Molecule Size: Rate of absorption increases inversely with the size of a drug molecule. However, several studies have demonstrated that, absorption mechanisms vary significantly for different sizes of molecules. For instance, larger molecules get absorbed either by endocytosis or facilitated diffusion, whereas smaller molecules are absorbed via aqueous diffusion or through lipid channels.
     Degree of Ionization: Degree of ionization has a direct impact on drug absorption. Higher degree of ionization of a drug molecule results in poor solubility. As a general rule, basic drugs get ionized in acidic medium and are therefore, poorly soluble in acidic medium. The same rule applies to acidic drugs in basic medium.
     Formulation: The formulation process involves the addition of certain excipients, which are inactive substances that augment the properties of the drugs. Despite being inactive, these substances can influence drug bioavailability.
     Concentration: According to Fick’s law of diffusion, higher drug concentration in a tissue microenvironment, leads to higher flux through the membrane, resulting in a high rate of absorption.

    Further, given the rapid increase in the number of NCEs with low solubility and considering that this trend persists in the future as well, there is likely to be a surge in the demand for technologies that facilitate bioavailability enhancement. There are a number of technologies which are already available for improving drug bioavailability. Broadly these technologies can be distributed across three main categories, namely physical, chemical and biological approaches. However, as pharmacological interventions gradually become more complex and novel drug classes are introduced, further innovation may be required in the development of better bioavailability enhancement techniques / methods.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html or email sales@rootsanalysis.com

    You may also be interested in the following titles:
    1. RNAi Market: Therapeutics and Technologies (Focus on siRNA, miRNA, shRNA and DNA) (3rd Edition): Industry Trends and Global Forecasts, 2022-2035
    2. Global Therapeutic Vaccines Market: Industry Trends and Global Forecasts, 2022-2035

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com






    THE PHARMACEUTICAL INDUSTRY IS PRESENTLY EXPERIENCING A PROMINENT NEED FOR BIOAVAILABILITY ENHANCEMENT TECHNOLOGIES AND SERVICES Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug. Bioavailability refers to the proportion of a drug that reaches systemic circulation unaltered, post dose administration. Additionally, it is a direct consequence of the absorption potential of an active pharmaceutical ingredient (API). The bioavailability of a drug is dependent on several factors, such as solubility, route of administration and metabolism of the drug post administration. The following figure provides different factors that have been reported to impact drug bioavailability either directly or indirectly. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/198/request-sample.html  Solubility: The solubility of a substance refers to its ability to dissolve in a solvent and form a homogeneous system. Drug solubility is considered to be one of the most important factors responsible for enabling a therapeutic intervention to be efficiently distributed via systemic circulation. It is worth highlighting that a drug’s solubility is directly proportional to its bioavailability and hence, is one of the primary parameters that is modified during bioavailability enhancement  Permeability: Permeability refers to the ability of a molecule to pass through biological membranes. Similar to solubility, drug permeability plays a key role in its absorption and systemic distribution. Membrane based efflux mechanisms and other structural barriers are the major biological elements responsible for poor permeability of drugs. Permeability of a drug is also proportional to its bioavailability; however, it is possible to improve this characteristic by modifying the physiochemical properties of the drug to render them more suitable for absorption across different types of biological membranes.  Molecule Size: Rate of absorption increases inversely with the size of a drug molecule. However, several studies have demonstrated that, absorption mechanisms vary significantly for different sizes of molecules. For instance, larger molecules get absorbed either by endocytosis or facilitated diffusion, whereas smaller molecules are absorbed via aqueous diffusion or through lipid channels.  Degree of Ionization: Degree of ionization has a direct impact on drug absorption. Higher degree of ionization of a drug molecule results in poor solubility. As a general rule, basic drugs get ionized in acidic medium and are therefore, poorly soluble in acidic medium. The same rule applies to acidic drugs in basic medium.  Formulation: The formulation process involves the addition of certain excipients, which are inactive substances that augment the properties of the drugs. Despite being inactive, these substances can influence drug bioavailability.  Concentration: According to Fick’s law of diffusion, higher drug concentration in a tissue microenvironment, leads to higher flux through the membrane, resulting in a high rate of absorption. Further, given the rapid increase in the number of NCEs with low solubility and considering that this trend persists in the future as well, there is likely to be a surge in the demand for technologies that facilitate bioavailability enhancement. There are a number of technologies which are already available for improving drug bioavailability. Broadly these technologies can be distributed across three main categories, namely physical, chemical and biological approaches. However, as pharmacological interventions gradually become more complex and novel drug classes are introduced, further innovation may be required in the development of better bioavailability enhancement techniques / methods. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. RNAi Market: Therapeutics and Technologies (Focus on siRNA, miRNA, shRNA and DNA) (3rd Edition): Industry Trends and Global Forecasts, 2022-2035 2. Global Therapeutic Vaccines Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com
    Request Sample - Bioavailability Enhancement Technologies and Services | Market Size | 2035
    The space of bioavailability enhancement technologies and services, driven by the increase in number of BCS II and BCS IV molecules in early phases of development, is likely to grow at CAGR of ~11%, till 2035
    0 Comments 0 Shares
  • The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040, claims Roots Analysis

    SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share.

    Roots Analysis has announced the addition of “SARM1 Inhibitors Therapeutics Market , 2022 – 2040” report to its list of offerings.

    Presently, several industry and non-industry stakeholders are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorders across various preclinical studies and early stages of clinical development, worldwide. With the ongoing pace of innovation in this field, increasing R&D activity and promising pre-clinical data, several promising leads are anticipated to be commercially launched over the coming decade and SARM1 targeting therapeutics market is anticipated to witness substantial growth in the mid to long-term.

    To request a sample copy / brochure of this report, please visit
    https://www.rootsanalysis.com/reports/sarm1-inhibitors-market/request-sample.html


    Key Market Insights

    Presently, several SARM1 targeting therapy candidates are being developed by various industry players
    About 65% of the pipeline candidates are currently being evaluated in the preclinical stages of development, followed by those currently in the discovery stage (35%). Further, it is worth mentioning that close to 85% of the SARM1 inhibitors are small molecules.

    Currently, a number of companies claim to be engaged in the development of SARM1 inhibitors
    The SARM1 inhibitors market is dominated by the presence of large companies (81%), followed by small players (19%). In addition, around 20% of the players were established post-2010.

    120+ articles related to SARM1 inhibitors have been published between 2011 and 2022
    Majority (81%) of the articles published in this domain were research papers, followed by review papers (12%). It is important to note that more than 70% of the total number of articles were published post-2018.

    Over 30 grants have been awarded for research related to SARM1 inhibitors, since 2014
    Close to 40% of the total amount was awarded under the R01 mechanism (which supports research projects). Further, genetics and neurology emerged as the key research departments, having received 34% of the total grants, each.

    70+ patents related to SARM1 targeting therapeutics have been filed / granted till 2022
    Over the years, the number of patents filed for SARM1 inhibitors has increased gradually; majority of the patents have been filed / granted in 2021. Most of the patents in this domain are patent applications (96%), followed by granted patents (3%).

    North America is anticipated to capture more than 65% share of the market, by 2040
    By 2040, the market revenues are likely to be driven by the sales of small molecules (95%) being developed as SARM1 inhibitors. Further, sales of therapeutics targeting multiple sclerosis are likely to contribute to a majority share (~40%) of revenues, in the long term.


    For additional details, please visit
    https://www.rootsanalysis.com/reports/sarm1-inhibitors-market.html
    or email sales@rootsanalysis.com

    You may also be interested in the following titles:
    1. RNAi Market: Therapeutics and Technologies (Focus on siRNA, miRNA, shRNA and DNA) (3rd Edition): Industry Trends and Global Forecasts, 2022-2035
    2. Global Therapeutic Vaccines Market: Industry Trends and Global Forecasts, 2022-2035

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com


    The SARM1 targeting therapeutics market is projected to grow at a CAGR of 102.1%, during the period 2033-2040, claims Roots Analysis SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share. Roots Analysis has announced the addition of “SARM1 Inhibitors Therapeutics Market , 2022 – 2040” report to its list of offerings. Presently, several industry and non-industry stakeholders are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorders across various preclinical studies and early stages of clinical development, worldwide. With the ongoing pace of innovation in this field, increasing R&D activity and promising pre-clinical data, several promising leads are anticipated to be commercially launched over the coming decade and SARM1 targeting therapeutics market is anticipated to witness substantial growth in the mid to long-term. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/sarm1-inhibitors-market/request-sample.html Key Market Insights Presently, several SARM1 targeting therapy candidates are being developed by various industry players About 65% of the pipeline candidates are currently being evaluated in the preclinical stages of development, followed by those currently in the discovery stage (35%). Further, it is worth mentioning that close to 85% of the SARM1 inhibitors are small molecules. Currently, a number of companies claim to be engaged in the development of SARM1 inhibitors The SARM1 inhibitors market is dominated by the presence of large companies (81%), followed by small players (19%). In addition, around 20% of the players were established post-2010. 120+ articles related to SARM1 inhibitors have been published between 2011 and 2022 Majority (81%) of the articles published in this domain were research papers, followed by review papers (12%). It is important to note that more than 70% of the total number of articles were published post-2018. Over 30 grants have been awarded for research related to SARM1 inhibitors, since 2014 Close to 40% of the total amount was awarded under the R01 mechanism (which supports research projects). Further, genetics and neurology emerged as the key research departments, having received 34% of the total grants, each. 70+ patents related to SARM1 targeting therapeutics have been filed / granted till 2022 Over the years, the number of patents filed for SARM1 inhibitors has increased gradually; majority of the patents have been filed / granted in 2021. Most of the patents in this domain are patent applications (96%), followed by granted patents (3%). North America is anticipated to capture more than 65% share of the market, by 2040 By 2040, the market revenues are likely to be driven by the sales of small molecules (95%) being developed as SARM1 inhibitors. Further, sales of therapeutics targeting multiple sclerosis are likely to contribute to a majority share (~40%) of revenues, in the long term. For additional details, please visit https://www.rootsanalysis.com/reports/sarm1-inhibitors-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. RNAi Market: Therapeutics and Technologies (Focus on siRNA, miRNA, shRNA and DNA) (3rd Edition): Industry Trends and Global Forecasts, 2022-2035 2. Global Therapeutic Vaccines Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com
    Request Sample - SARM1 Inhibitors Market | Industry Analysis | Market Size | 2040
    SARM1 Inhibitors market, driven by active research and growing pipeline, is anticipated to grow at over 100% CAGR after first approval in 2033
    0 Comments 0 Shares
  • Buy an Air Vaccine to Breathe Fresh and Pollutant-Free Air
    https://www.atoallinks.com/2022/buy-an-air-vaccine-to-breathe-fresh-and-pollutant-free-air/
    Buy an Air Vaccine to Breathe Fresh and Pollutant-Free Air https://www.atoallinks.com/2022/buy-an-air-vaccine-to-breathe-fresh-and-pollutant-free-air/
    Buy an Air Vaccine to Breathe Fresh and Pollutant-Free Air - AtoAllinks
    Did you know that the average PM2.5 concentration in the USA is two times higher than the annual recommended air quality value by the World Health Organization (WHO)? Although the country has a relatively good air quality index, states like Oregon, Michigan, and California suffer...
    0 Comments 0 Shares
  • https://world-signals.com/news/2022/12/05/the-police-forcibly-sent-a-cardiologist-to-psychiatry-for-messages-on-the-social-network/
    The police forcibly sent a cardiologist to psychiatry for messages on the social network
    #news #freedom #freespeech #vaccine #switzerland #wef #terror #health #mandates #covid #covid19
    https://world-signals.com/news/2022/12/05/the-police-forcibly-sent-a-cardiologist-to-psychiatry-for-messages-on-the-social-network/ The police forcibly sent a cardiologist to psychiatry for messages on the social network #news #freedom #freespeech #vaccine #switzerland #wef #terror #health #mandates #covid #covid19
    0 Comments 0 Shares
  • https://emfprotection.one/emf-protection-devices-pendants-shields 5G EMF radiation from cell phones and 5G towers is a deep penetrating type of harmful radiation that literally cooks your cells (brain, DNA, immune system, nervous system.) EMF protection pendants and necklaces can keep your DNA, Immune System, heart and brainwaves (as seen in EKG and EEG) free from very harmful 5G EMF Waves. The newer vaccines work WITH 5G EMF radiation to wipe out your immune system! If you have chronic headaches, irregular heartbeats, sinusitis, you may be absorbing these harmful radiation waves. #5g #emf #vaccines #radiation #emfprotection
    https://emfprotection.one/emf-protection-devices-pendants-shields 5G EMF radiation from cell phones and 5G towers is a deep penetrating type of harmful radiation that literally cooks your cells (brain, DNA, immune system, nervous system.) EMF protection pendants and necklaces can keep your DNA, Immune System, heart and brainwaves (as seen in EKG and EEG) free from very harmful 5G EMF Waves. The newer vaccines work WITH 5G EMF radiation to wipe out your immune system! If you have chronic headaches, irregular heartbeats, sinusitis, you may be absorbing these harmful radiation waves. #5g #emf #vaccines #radiation #emfprotection
    1
    0 Comments 0 Shares
  • https://world-signals.com/news/2022/12/03/you-wanted-to-travel-freely-this-is-the-price-you-now-have-to-pay/
    You wanted to travel freely - this is the price you now have to pay
    #news #freedom #travel #vaccine #sideeffects #cancer #covid #covid19
    https://world-signals.com/news/2022/12/03/you-wanted-to-travel-freely-this-is-the-price-you-now-have-to-pay/ You wanted to travel freely - this is the price you now have to pay #news #freedom #travel #vaccine #sideeffects #cancer #covid #covid19
    0 Comments 0 Shares

No results to show

No results to show

No results to show